王子新材(002735.SZ):相關股東劉淮健擬將江蘇栢煜13.33%股權轉讓給王子創投
格隆匯1月27日丨王子新材(002735.SZ)公佈,公司二級控股子公司江蘇栢煜包裝材料科技有限公司(“江蘇栢煜”)的股東劉淮健擬與公司控股子公司霍爾果斯王子創業投資有限公司(“王子創投”)簽署股權轉讓協議,將其持有的江蘇栢煜13.33%股權以75萬元人民幣轉讓給王子創投,其他股東放棄優先購買權。上述股權轉讓完成後,江蘇栢煜仍為公司二級控股子公司。同時授權管理層處理本次投資有關事宜。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.